Prof Adam Vogel
Professor in Speech Pathology
Department of Audiology and Speech Pathology
308 Scholarly works
34 Projects
HIGHLIGHTS
2026
Journal article
Acetyl-carnitine improves hyperactivity and learning deficits in KAT6A haploinsufficient mice
DOI: 10.26508/lsa.2025035492026
Journal article
Development and validation of the dysarthria impact scale: a patient-reported outcome for motor speech disorders
DOI: 10.1007/s00415-026-13740-12026
Journal article
Red flags for speech impairment: who should we refer to speech therapy?
DOI: 10.1136/archdischild-2025-3292792025
Research grants (ARC, NHMRC, MRFF)
Implementing ParkinsonNet to Improve Equitable Access to High Quality Care for People With Parkinson's Disease in Rural and Remote Australia
2023
Research grants (ARC, NHMRC, MRFF)
Detecting and Tracking Alertness Using Speech Biometrics
2021
Research grants (ARC, NHMRC, MRFF)
Music Attuned Technology Care eHealth (MATCH): A Music Based Mobile eHealth Solution to Support Care of People With Dementia
2017
Journal article
Motor speech signature of behavioral variant frontotemporal dementia: Refining the phenotype
DOI: 10.1212/WNL.0000000000004248
RECENT SCHOLARLY WORKS
2026
Journal article
P148: Multimodal characterization of neurological symptoms in Niemann-Pick disease type C
DOI: 10.1016/j.gimo.2026.1036422026
Journal article
P116: Noninvasive markers of central and musculoskeletal symptoms in infantile- and late-onset Pompe disease*
DOI: 10.1016/j.gimo.2026.1036102026
Journal article
Understanding speech and language in KIF1A-associated neurological disorder
DOI: 10.1038/s41431-025-01867-02025
Journal article
Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults
DOI: 10.1007/s11357-025-01739-x2025
Journal article
To Treat or Not to Treat: A Scoping Review of Speech Treatment for Dysarthria in Amyotrophic Lateral Sclerosis (ALS)
DOI: 10.3390/healthcare131924342025
Journal article
Examination of speech processing in noise reveals cognitive deficits in early Huntington's disease
DOI: 10.1016/j.cortex.2025.07.0072025
Journal article
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis
DOI: 10.1016/j.ebiom.2025.105840
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
Centre for Investigating Mechanisms, Peripheral and Central Traits (IMPACT) in Chronic Cough